MiR‐885‐3p is down‐regulated in peripheral blood mononuclear cells from T1D patients and regulates the inflammatory response via targeting TLR4/NF‐κB signaling

miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3

(2018) Magdalena Zurawek et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Type 1 diabetes

(2018) Linda A DiMeglio et al.   LANCET

Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes

(2018) Linda Åkerman et al.   PLoS One

A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes

(2018) Isabelle Serr et al.   Science Translational Medicine

Long noncoding RNA gastric cancer-related lncRNA1 mediates gastric malignancy through miRNA-885-3p and cyclin-dependent kinase 4

(2018) Zhijuan Lin et al.   Cell Death & Disease

Genetic risk scores in adult-onset type 1 diabetes

(2018) Richard David Leslie et al.   Lancet Diabetes & Endocrinology

Nanoceria suppresses multiple low doses of streptozotocin-induced Type 1 diabetes by inhibition of Nrf2/NF-κB pathway and reduction of apoptosis

(2018) Amit Khurana et al.   Nanomedicine

Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression

(2017) Guido Sebastiani et al.   Scientific Reports

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

(2016) James J. Chamberlain et al.   ANNALS OF INTERNAL MEDICINE

Beyond Genetics: What Causes Type 1 Diabetes

(2016) Zhen Wang et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

APPL1 prevents pancreatic beta cell death and inflammation by dampening NFκB activation in a mouse model of type 1 diabetes

(2016) Xue Jiang et al.   DIABETOLOGIA

Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody

(2015) Kyle J. Bednar et al.   DIABETES

Global toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy

(2014) Ishwarlal Jialal et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Abnormal NF- B Function Characterizes Human Type 1 Diabetes Dendritic Cells and Monocytes

(2014) Z. U. A. Mollah et al.   JOURNAL OF IMMUNOLOGY

MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling

(2014) F Xiao et al.   ONCOGENE

Cell-Specific Post-Transcriptional Regulation of γ-Synuclein Gene by Micro-RNAs

(2013) Irina Surgucheva et al.   PLoS One

Dysregulated Toll-Like Receptor-Induced Interleukin-1  and Interleukin-6 Responses in Subjects at Risk for the Development of Type 1 Diabetes

(2012) A. K. Alkanani et al.   DIABETES

Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure

(2011) Yiping Huang et al.   CELL CYCLE

Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes

(2011) Sridevi Devaraj et al.   CYTOKINE

Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity

(2011) Taro Kawai et al.   IMMUNITY

Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications

(2010) Sridevi Devaraj et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes

(2009) S. Devaraj et al.   DIABETOLOGIA

Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State

(2007) Sridevi Devaraj et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM